ST. PAUL, Minn., March 24 /PRNewswire/ — Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today the launch of its specialty pharmacy program, Triessent(TM). Prime will begin enrollment in Triessent in mid 2008, offering patients complete specialty pharmacy management services, including comprehensive support to members with conditions that require specialty medications, as well as distribution of the medications themselves.
The introduction of Triessent represents the next stage for specialty pharmacy management for members and clients. The program directly addresses one of the leading contributors to rising health care costs by providing an approach to specialty pharmaceutical management that integrates pharmacy and medical benefits for Blue Cross and Blue Shield clients across the nation.
The development of Triessent has focused on three core capabilities as a foundation for a complete specialty management program: safe and efficient delivery of specialty medications; education and guidance from experienced professionals for both clinical care management and benefit design; and integrated management of medical and pharmacy programs. Through Triessent, members will experience the high-touch, personalized and coordinated care management they need to manage their specialty conditions.
As an important milestone in the development of Triessent, Prime has selected Pittsburgh-based Medmark, A Walgreens Specialty Pharmacy , as its single-source distribution provider.
“Prime believes the complexity of specialty pharmacy is too important to simply outsource,” says Tom Solberg, Assistant Vice President of Specialty at Prime. “Medmark’s proven track record complements Prime’s existing specialty core capabilities as a pharmacy benefit manager and will allow Prime to offer a complete specialty pharmacy program through Triessent. Prime is committed to providing a variety of solutions to help our clients manage specialty spend and strengthen their ability to compete effectively in the specialty marketplace with a complete specialty solution.”
Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and thirdparty administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 10 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com/.
Prime Therapeutics
CONTACT: Sheila Thelemann, Sr. Manager, Public Relations and CorporateCommunications of Prime Therapeutics, +1-651-414-1863,[email protected]
Web site: http://www.primetherapeutics.com/
Comments